BlackRock Amends Repligen Stake, Signals Continued Confidence
Ticker: RGEN · Form: SC 13G/A · Filed: Jan 23, 2024 · CIK: 730272
| Field | Detail |
|---|---|
| Company | Repligen Corp (RGEN) |
| Form Type | SC 13G/A |
| Filed Date | Jan 23, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock still owns a chunk of Repligen, good sign for the stock!**
AI Summary
BlackRock, Inc. filed an amended SC 13G/A on January 23, 2024, disclosing its ownership in Repligen Corporation (NASDAQ: RGEN) as of December 31, 2023. This amendment, number 2, indicates a change in their beneficial ownership of Repligen's Common Stock. For investors, this filing shows that a major institutional investor like BlackRock continues to hold a significant stake in Repligen, signaling ongoing confidence in the company's long-term prospects.
Why It Matters
This filing confirms BlackRock's continued significant investment in Repligen, which can reassure current and potential investors about the stock's institutional backing.
Risk Assessment
Risk Level: low — This filing is a routine update from a major institutional investor and does not indicate any immediate negative risks.
Analyst Insight
Investors should note BlackRock's continued presence as a major shareholder, which can be a positive signal, but should also conduct their own due diligence on Repligen's fundamentals.
Key Players & Entities
- BlackRock, Inc. (company) — the reporting person and institutional investor
- Repligen Corporation (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 23, 2024 (date) — the filing date of the SC 13G/A amendment
- 759916109 (number) — the CUSIP number for Repligen Corporation's Common Stock
Forward-Looking Statements
- BlackRock will maintain a significant stake in Repligen Corporation throughout 2024. (BlackRock, Inc.) — high confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing under the Securities Exchange Act of 1934, specifically Amendment No: 2.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., identified by CIK 0001364742.
What is the subject company whose securities are being reported?
The subject company is Repligen Corporation, identified by CIK 0000730272, with its Common Stock being the class of securities.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the 'X' in the appropriate box.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 23, 2024 regarding REPLIGEN CORP (RGEN).